| 000 | 01130 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250516043542.0 | ||
| 264 | 0 | _c20110701 | |
| 008 | 201107s 0 0 jpn d | ||
| 022 | _a0385-0684 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTauchi, Tetsuzo | |
| 245 | 0 | 0 |
_a[Mechanism and overcome against drug resistance to imatinib for treatment of chronic myeloid leukemia]. _h[electronic resource] |
| 260 |
_bGan to kagaku ryoho. Cancer & chemotherapy _cMay 2011 |
||
| 300 |
_a749-53 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aBenzamides |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 |
_aFusion Proteins, bcr-abl _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImatinib Mesylate |
| 650 | 0 | 4 |
_aLeukemia, Myelogenous, Chronic, BCR-ABL Positive _xdrug therapy |
| 650 | 0 | 4 |
_aOrganic Cation Transporter 1 _xmetabolism |
| 650 | 0 | 4 |
_aPiperazines _xtherapeutic use |
| 650 | 0 | 4 |
_aPyrimidines _xtherapeutic use |
| 700 | 1 | _aOyashiki, Kazuma | |
| 773 | 0 |
_tGan to kagaku ryoho. Cancer & chemotherapy _gvol. 38 _gno. 5 _gp. 749-53 |
|
| 999 |
_c20955972 _d20955972 |
||